darifenacin and Granuloma

darifenacin has been researched along with Granuloma* in 1 studies

Other Studies

1 other study(ies) available for darifenacin and Granuloma

Article	Year
Interstitial granulomatous dermatitis associated with darifenacin. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:9 Interstitial granulomatous dermatitis is most commonly associated with rheumatoid arthritis (RA) but may be induced by medications as well. Darifenacin is a muscarinic antagonist which was FDA approved for the treatment of overactive bladder in December 2004. The authors describe a case of interstitial granulomatous dermatitis associated with darifenacin. Topics: Benzofurans; Drug Eruptions; Female; Granuloma; Humans; Middle Aged; Muscarinic Antagonists; Pyrrolidines; Urinary Bladder, Overactive	2008

Article

Year

Interstitial granulomatous dermatitis associated with darifenacin.

Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:9

Interstitial granulomatous dermatitis is most commonly associated with rheumatoid arthritis (RA) but may be induced by medications as well. Darifenacin is a muscarinic antagonist which was FDA approved for the treatment of overactive bladder in December 2004. The authors describe a case of interstitial granulomatous dermatitis associated with darifenacin.

Topics: Benzofurans; Drug Eruptions; Female; Granuloma; Humans; Middle Aged; Muscarinic Antagonists; Pyrrolidines; Urinary Bladder, Overactive

2008